On Demand

If not you, then who?

Dr. Roger Henderson - Senior GP, Shropshire

Ever wondered how you can discuss smoking cessation in a COPD consultation? Or what does a brief consultation on smoking cessation look like?  These webinars bring solutions to these two challenges, to life.

On Demand

IBRANCE® (palbociclib) Oligometastases

Dr. John Connibear

In this video Dr. Connibear provides his professional opinion on the following topics:

  • Definition of oligometastatic disease
  • What challenges do oligometastases present in breast cancer?
  • How do you decide treatment for patients with metastatic breast cancer?
  • How might we drive better outcomes in oligometastatic breast cancer?
On Demand

IBRANCE® (palbociclib) locally advanced breast cancer

Dr. Henry Cain

In this video Henry Cain provides his professional opinion on the following topics:

  • What is locally advanced inoperable breast cancer?
  • What is the significance of the MDT, and of the patient’s opinion and quality of life when deciding therapy?
  • What could CDK4/6 inhibitors, such as Ibrance mean for patients with ER+, HER2- locally advanced disease?
On Demand

Implementing smoking cessation in hospitals

Matthew Evison - Consultant in Respiratory Medicine, Greater Manchester

Gareth Jones - Consultant Respiratory Physician, Royal Liverpool University Hospital

Hosted by Noel Baxter, GP and clinical commissioner for NHS Southwark and chair elect for the Primary Care Respiratory Society UK (PCRS-UK).

On Demand

Tissue sample acquisition in NSCLC patients

Dr Neal Navani

Dr Neal Navani answers the key question: What is the importance of optimal tissue acquisition in lung cancer patients? and gives his recommendations on optimal sample acquisition.

On Demand

The IMPACT webinar series - guidance for Cardiovascular Physicians

Dr Sandy Gupta

Bernadette Downey

1. Dr Sandy Gupta and Bernadette Downey discuss the ‘deadly duo’ of smoking and cardiovascular disease and the health benefits of smoking cessation. They also highlight their experiences of the changing environment of smoking cessation services and re-enforce the need for a whole system approach across primary and secondary care.

On Demand

The IMPACT webinar series - guidance for General Practitioners and Nurses

Dr Stephen Gaduzo

Nurse Lisa Fendell

1. GP Stephen Gaduzo and Smoking Cessation Advisor Lisa Fendall discuss how smoking is a significant cause of long term diseases such as COPD, cardiovascular disease and diabetes and the substantial health benefits of quitting smoking for these patient groups.

On Demand

IBRANCE® (palbociclib) visceral disease

Peter Schmid | Professor of Cancer Medicine at Barts Cancer Institute

In the visceral disease video Prof Peter Schmid provides his professional opinion on the following topics:

  • Definition of visceral metastasis in breast cancer
  • What factors do you consider when a patient presents with visceral disease
  • How CDK4/6 inhibitors have changed the management of visceral disease.
  • What have CDK4/6 inhibitors meant for quality of life in this patient group
  • When would you prescribe Ibrance and endocrine therapy for your patient with visceral disease
On Demand

IBRANCE® (palbociclib) interactive case study

Chris Poole | Consultant Medical Oncologist, University Hospital Coventry And Warwickshire

In this video Prof Chris Poole provides his professional opinion on the following topics:

  • Case of a patient with visceral metastasis
On Demand

The IMPACT webinar series - guidance for Respiratory Physicians

Keir Lewis - Swansea University

1. Professor Keir Lewis discusses the burden of smoking and the impact that the subsequent chronic respiratory conditions in patients has on the NHS.